Guilt and shame drive end-of-life treatment decisions in cancer patients

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Guilt and shame – not hope for recovery – are among the most common reasons terminally ill cancer patients continue with minimally beneficial treatments at the end of life, according to Rutgers researchers.